COMPOUND, PREPARATION METHOD, AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITION THEREOF
The present invention provides a compound, a preparation method, and lipid nanoparticles and a pharmaceutical composition thereof. The compound comprises: at least one structural general formula of formula (I-1), or the compound as a pharmaceutically acceptable salt, prodrug, or isomer thereof. The...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SUN, Jingbo LIU, Bing JIA, Kan XU, Zebin LU, Qingqing DENG, Shuang HU, Hongpeng JIANG, Jianhao ZHOU, Wujun ZHONG, Tianyi |
| description | The present invention provides a compound, a preparation method, and lipid nanoparticles and a pharmaceutical composition thereof. The compound comprises: at least one structural general formula of formula (I-1), or the compound as a pharmaceutically acceptable salt, prodrug, or isomer thereof. The compound of the present invention increases structural variety, thereby increasing the structural variety of lipid molecules. The structure of the compound directly provides biodegradability. The L1a, L1b and L1c of the compound can be exchanged as desired with L2, allowing the compound to directly accommodate other types of molecules, such as steroids, peptides, etc., so as to perform direct and rapid screening, thereby allowing for expanding the functionality of a cationic lipid compound itself, allowing for functional molecules to be directly coupled to the cationic lipid compound, thus having the effect of directly expanding functionality. The ease of substitution of the L structure of the compound enables the |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024149370A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024149370A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024149370A13</originalsourceid><addsrcrecordid>eNrjZIhx9vcN8A_1c9FRCAhyDXAMcgzx9PdT8HUN8fAHijn6uSj4eAZ4uij4Ofr5A6VDPJ19XIPB4gEejkG-js6uoUAxRx8FsEHBnmDtIR6uQa7-bjwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jAyMTQxNLY3MDR0Jg4VQCMPzNl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOUND, PREPARATION METHOD, AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITION THEREOF</title><source>esp@cenet</source><creator>SUN, Jingbo ; LIU, Bing ; JIA, Kan ; XU, Zebin ; LU, Qingqing ; DENG, Shuang ; HU, Hongpeng ; JIANG, Jianhao ; ZHOU, Wujun ; ZHONG, Tianyi</creator><creatorcontrib>SUN, Jingbo ; LIU, Bing ; JIA, Kan ; XU, Zebin ; LU, Qingqing ; DENG, Shuang ; HU, Hongpeng ; JIANG, Jianhao ; ZHOU, Wujun ; ZHONG, Tianyi</creatorcontrib><description>The present invention provides a compound, a preparation method, and lipid nanoparticles and a pharmaceutical composition thereof. The compound comprises: at least one structural general formula of formula (I-1), or the compound as a pharmaceutically acceptable salt, prodrug, or isomer thereof. The compound of the present invention increases structural variety, thereby increasing the structural variety of lipid molecules. The structure of the compound directly provides biodegradability. The L1a, L1b and L1c of the compound can be exchanged as desired with L2, allowing the compound to directly accommodate other types of molecules, such as steroids, peptides, etc., so as to perform direct and rapid screening, thereby allowing for expanding the functionality of a cationic lipid compound itself, allowing for functional molecules to be directly coupled to the cationic lipid compound, thus having the effect of directly expanding functionality. The ease of substitution of the L structure of the compound enables the</description><language>chi ; eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240718&DB=EPODOC&CC=WO&NR=2024149370A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240718&DB=EPODOC&CC=WO&NR=2024149370A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SUN, Jingbo</creatorcontrib><creatorcontrib>LIU, Bing</creatorcontrib><creatorcontrib>JIA, Kan</creatorcontrib><creatorcontrib>XU, Zebin</creatorcontrib><creatorcontrib>LU, Qingqing</creatorcontrib><creatorcontrib>DENG, Shuang</creatorcontrib><creatorcontrib>HU, Hongpeng</creatorcontrib><creatorcontrib>JIANG, Jianhao</creatorcontrib><creatorcontrib>ZHOU, Wujun</creatorcontrib><creatorcontrib>ZHONG, Tianyi</creatorcontrib><title>COMPOUND, PREPARATION METHOD, AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITION THEREOF</title><description>The present invention provides a compound, a preparation method, and lipid nanoparticles and a pharmaceutical composition thereof. The compound comprises: at least one structural general formula of formula (I-1), or the compound as a pharmaceutically acceptable salt, prodrug, or isomer thereof. The compound of the present invention increases structural variety, thereby increasing the structural variety of lipid molecules. The structure of the compound directly provides biodegradability. The L1a, L1b and L1c of the compound can be exchanged as desired with L2, allowing the compound to directly accommodate other types of molecules, such as steroids, peptides, etc., so as to perform direct and rapid screening, thereby allowing for expanding the functionality of a cationic lipid compound itself, allowing for functional molecules to be directly coupled to the cationic lipid compound, thus having the effect of directly expanding functionality. The ease of substitution of the L structure of the compound enables the</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIhx9vcN8A_1c9FRCAhyDXAMcgzx9PdT8HUN8fAHijn6uSj4eAZ4uij4Ofr5A6VDPJ19XIPB4gEejkG-js6uoUAxRx8FsEHBnmDtIR6uQa7-bjwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jAyMTQxNLY3MDR0Jg4VQCMPzNl</recordid><startdate>20240718</startdate><enddate>20240718</enddate><creator>SUN, Jingbo</creator><creator>LIU, Bing</creator><creator>JIA, Kan</creator><creator>XU, Zebin</creator><creator>LU, Qingqing</creator><creator>DENG, Shuang</creator><creator>HU, Hongpeng</creator><creator>JIANG, Jianhao</creator><creator>ZHOU, Wujun</creator><creator>ZHONG, Tianyi</creator><scope>EVB</scope></search><sort><creationdate>20240718</creationdate><title>COMPOUND, PREPARATION METHOD, AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITION THEREOF</title><author>SUN, Jingbo ; LIU, Bing ; JIA, Kan ; XU, Zebin ; LU, Qingqing ; DENG, Shuang ; HU, Hongpeng ; JIANG, Jianhao ; ZHOU, Wujun ; ZHONG, Tianyi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024149370A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2024</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SUN, Jingbo</creatorcontrib><creatorcontrib>LIU, Bing</creatorcontrib><creatorcontrib>JIA, Kan</creatorcontrib><creatorcontrib>XU, Zebin</creatorcontrib><creatorcontrib>LU, Qingqing</creatorcontrib><creatorcontrib>DENG, Shuang</creatorcontrib><creatorcontrib>HU, Hongpeng</creatorcontrib><creatorcontrib>JIANG, Jianhao</creatorcontrib><creatorcontrib>ZHOU, Wujun</creatorcontrib><creatorcontrib>ZHONG, Tianyi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SUN, Jingbo</au><au>LIU, Bing</au><au>JIA, Kan</au><au>XU, Zebin</au><au>LU, Qingqing</au><au>DENG, Shuang</au><au>HU, Hongpeng</au><au>JIANG, Jianhao</au><au>ZHOU, Wujun</au><au>ZHONG, Tianyi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOUND, PREPARATION METHOD, AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITION THEREOF</title><date>2024-07-18</date><risdate>2024</risdate><abstract>The present invention provides a compound, a preparation method, and lipid nanoparticles and a pharmaceutical composition thereof. The compound comprises: at least one structural general formula of formula (I-1), or the compound as a pharmaceutically acceptable salt, prodrug, or isomer thereof. The compound of the present invention increases structural variety, thereby increasing the structural variety of lipid molecules. The structure of the compound directly provides biodegradability. The L1a, L1b and L1c of the compound can be exchanged as desired with L2, allowing the compound to directly accommodate other types of molecules, such as steroids, peptides, etc., so as to perform direct and rapid screening, thereby allowing for expanding the functionality of a cationic lipid compound itself, allowing for functional molecules to be directly coupled to the cationic lipid compound, thus having the effect of directly expanding functionality. The ease of substitution of the L structure of the compound enables the</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng ; fre |
| recordid | cdi_epo_espacenet_WO2024149370A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | COMPOUND, PREPARATION METHOD, AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITION THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A34%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SUN,%20Jingbo&rft.date=2024-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024149370A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |